Zhangzhou Pientzehuang Pharmaceutical.Ltd provided earnings guidance for the year 2017. For the year, the company predicts that the net profit belonging to shareholders of the listed company in 2017 will increase by between RMB 214.45 million and RMB 321.68 million with an increase of between 40% and 60% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 196.13 million and RMB 303.36 million with an increase of between 38% and 58% compared with the same period of the year before (based on the disclosed statistics according to relevant regulations).